tiprankstipranks

Steven H Stein Insider Profile

11 Followers
Steven H Stein, CMO & Head of Late-Stage Dev at Incyte, holds 73.25K shares in Incyte (Ticker: INCY), holds ― shares in Kura Oncology (Ticker: KURA), holds ― shares in Theseus Pharmaceuticals (Ticker: THRX).
tipranks
Steven H Stein

Steven H Stein
Incyte (INCY)
CMO & Head of Late-Stage Dev

Ranked #86,666 out of 107,514 Corporate Insiders

Profitable Transactions

44%
4 out of 9 Profitable Transactions

Average Return

-16.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
100.00%
0.00%
A breakdown of Steven H Stein's holdings

Insider Roles

Incyte
(INCY)
CMO & Head of Late-Stage Dev
Kura Oncology
(KURA)
Director
Roles that Steven H Stein holds in companies

Most Profitable Insider Trade

Stock:
Incyte
(INCY)
Rating:Informative Sell
Date:Jan 07, 2026 - Today
Return:+12.10%
The most profitable trade made by Steven H Stein

Steven H Stein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Incyte
Apr 17, 2026
CMO & Head of Late-Stage Dev
Uninformative Buy
$7.12M
Kura Oncology
Director
THRX
Theseus Pharmaceuticals
RPTX
Repare Therapeutics
List of latest transactions for each holding click on a transaction to see Steven H Stein's performance on stock

Steven H Stein insider profile FAQ

What is the percentage of profitable transactions made by Steven H Stein?
The percentage of profitable transactions made by Steven H Stein is 44%.
    What is the average return per transaction made by Steven H Stein?
    The average return per transaction made by Steven H Stein is -16.00%.
      What stocks does Steven H Stein hold?
      Steven H Stein holds: INCY, KURA, THRX, RPTX stocks.
        What was Steven H Stein’s latest transaction?
        Steven H Stein latest transaction was an Uninformative Buy of ―.
          What was Steven H Stein's most profitable transaction?
          Steven H Stein’s most profitable transaction was an Informative Sell of INCY stock on January 7, 2026. The return on the trade was 12.10%.
            What is Steven H Stein's role in Incyte?
            Steven H Stein's role in Incyte is CMO & Head of Late-Stage Dev.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.